Join Dr. Claudia de la Cruz, a dermatologist from Santiago, Chile, and Secretary of the International Psoriasis Council, as she describes what led her to specialize in the field of psoriasis. Understand her dedication to psoriasis patients and contributions to global psoriasis education.
Join us in welcoming George Han, Julia Yu-Huei Huang, and Dimitrios Ioannides as they bring their global expertise to the International Psoriasis Council (IPC), advancing psoriasis research, treatment, and patient care worldwide.
Catch up with 2018 IPC Fellow Dr. Jia Qi Chen as she shares insights into her experience, achievements, and challenges since completing her Fellowship. Read about her growth in the field of psoriasis and the impact of the IPC Fellowship on her career.
Access the latest insights from the 32nd European Academy of Dermatology and Venereology 2023 Congress (EADV) in Berlin, Germany. This report covers significant updates on psoriasis, including the International Psoriasis Council’s Symposium and late-breaking sessions. Download the full EADV Congress Report for a comprehensive overview of psoriasis presentation and treatment advancements.
Discover the latest in generalized pustular psoriasis (GPP) treatment with the approval of intravenous spesolimab by regulatory authorities. Read about a 48-week study on the subcutaneous delivery of spesolimab, showcasing promising results for preventing GPP flares. Learn about the evolving landscape of GPP treatment.
Learn the dynamics of psoriasis treatments, emphasizing patient adherence challenges. From evolving therapies to oral and biologic agents, understand real-world data and adherence patterns. Gain insights into long-term disease management and the crucial role of adherence in optimizing patient outcomes.
Discover the latest developments in global dermatology as key figures, such as Hervé Bachelez, MD, PhD, come together to endorse a commitment letter. Uncover their collaborative objectives and the potential implications for psoriasis care worldwide.
IPC stands for accessible treatment and universal healthcare on World Psoriasis Day and beyond. Gain insights from experts on the significance of timely care. Join the conversation and share your voice on psoriasis care.
Explore the journey of Leandro Leite in the IPC Fellowship Program, discovering his background, research achievements, program insights, and unique benefits, including mentorship and networking. Gain inspiration for considering this transformative path in psoriasis care and professional growth.
Join us in welcoming Irène Gallais Sérézal, Hazel Oon, Dharshini Sathishkumar, and Yu Sawada as they bring their global expertise to the International Psoriasis Council (IPC), advancing psoriasis research, treatment, and patient care on a worldwide scale.
Dr. Bruce Strober, Vice President of the International Psoriasis Council (IPC), has dedicated his career to understanding and treating psoriasis, contributing significantly to groundbreaking research and reshaping psoriasis treatment approaches. His work, from co-founding Central Connecticut Dermatology to his leadership in the IPC, demonstrates his enduring commitment to improving the lives of those affected by psoriasis.
UCB’s BIMZELX® (bimekizumab-bkzx) has been approved by the FDA, representing a major milestone in the treatment of adults with moderate to severe plaque psoriasis. Read more about this groundbreaking development.
